This inventor holds 7 USPTO granted patents and 2 EPO patents. Top assignee: Kyorin Pharmaceutical Co., Ltd.. Active years: 2017-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2026
Title: The Innovations of Yoshifumi Saito
Introduction
Yoshifumi Saito is a notable inventor based in Shimotsuga-gun, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic effects. With a total of 7 patents to his name, Saito's work continues to impact the medical community.
Latest Patents
Among his latest patents, Saito has developed a urea derivative or pharmacologically acceptable salt that exhibits a formyl peptide receptor like 1 (FPRL1) agonist effect. This invention relates to a compound represented by a specific general formula, which is crucial for creating pharmaceutical compositions that can enhance therapeutic outcomes.
Career Highlights
Saito is currently associated with Kyorin Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical innovation. His work focuses on creating compounds that can lead to advancements in medical treatments, showcasing his commitment to improving healthcare.
Collaborations
Saito has collaborated with notable colleagues such as Hiroyasu Takahashi and Kosuke Tsuda. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.
Conclusion
Yoshifumi Saito's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a key inventor in the industry. His ongoing work promises to lead to further advancements in medical treatments and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile